HZSY(SH:600191) Shang Hai Zheng Quan Bao·2025-12-18 21:00Core Viewpoint - The company, Baotou Huazi Industrial Co., Ltd., plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with an investment of 10 million yuan to enhance its product offerings and support its strategic development goals [2][3][11]. Group 1: Investment Overview - The investment amount for the establishment of the subsidiary is 10 million yuan [3]. - The subsidiary will be fully funded by the company, with 100% ownership [5][9]. - The establishment of the subsidiary aligns with the company's strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [5][11]. Group 2: Company Strategy and Product Development - The new subsidiary will focus on developing skincare products using xanthan gum and convenient nutritional meal replacement products using resistant dextrin [5][11]. - The subsidiary will leverage existing research and development platforms, including collaborations with academic institutions, to explore advancements in the health industry [6][11]. Group 3: Decision and Approval Process - The decision to establish the subsidiary was approved unanimously by the board of directors during a meeting held on December 18, 2025 [6][18]. - The investment does not require shareholder approval and is within the board's decision-making authority [4][7]. Group 4: Impact on the Company - The investment is expected to enhance the company's product value chain and extend its industrial chain [11]. - The funding for the investment will be sourced from the company's own funds, ensuring no adverse impact on the company's financial status [11][12].